Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man

Proc Natl Acad Sci U S A. 1981 Jan;78(1):440-4. doi: 10.1073/pnas.78.1.440.

Abstract

Vigorous lymphocyte proliferative response to synthetic polypeptides was observed in cells from 50 normal volunteers. Results indicated that 64% responded to poly(LHis, LGlu)-poly(DLAla)--poly(LLys) [(H, G)-A--L] and 54% to poly(LTyr, LGlu)-poly(DLAla)--poly(LLys) [(T, G)-A--L]. Subjects could be classified into high-, intermediate-, and non-responder phenotypes according to their stimulation indices. Family studies indicated that high responses to these antigens are inherited as histocompatibility antigen gene (HLA)-linked dominant traits. Two matings suggested gene complementation in response to (T, G)-A--L and (H, G)-A--L. One, with an intra-HLA recombinant offspring, provided evidence localizing the immune response gene(s) controlling lymphocyte proliferation to (T, G)-A--L and (H, G)-A--L, presumably the homologue to Ir-1 of mouse, closer to the HLA-B than to the HLA-D region.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Alleles
  • Child
  • Female
  • Gene Frequency
  • Genes, Dominant
  • Genes, MHC Class II*
  • Genetic Linkage
  • Humans
  • Infant, Newborn
  • Lymphocyte Activation / drug effects
  • Lymphocytes / immunology
  • Major Histocompatibility Complex*
  • Male
  • Peptides / chemical synthesis
  • Peptides / immunology*
  • Polymorphism, Genetic

Substances

  • Peptides